For many, the first sight of grey hair prompts a reach for hair dye. But emerging research suggests that this natural process might not simply be a sign of aging – it could be a vital defense mechanism against cancer. A groundbreaking study published in Nature Cell Biology reveals that grey hair isn’t just about losing pigment; it indicates the body is actively working to fight off potentially cancerous cell mutations in hair follicles.
These mutations, if left unchecked, could lead to malignant melanoma, the most dangerous form of skin cancer. Whereas melanoma accounts for a relatively small percentage of all skin cancers, This proves responsible for the vast majority of skin cancer deaths. Understanding how this natural defense system functions could pave the way for new strategies to prevent or treat the disease, which claims around 2,500 lives annually in the United Kingdom.
Researchers at the University of Tokyo investigated the process in mice, discovering that cells within hair follicles – specifically melanocyte stem cells, responsible for producing pigment – initiate a self-destruct sequence when they detect DNA damage that could lead to uncontrolled cell growth. This process, known as cell senescence, effectively halts potential cancer development, but similarly results in the loss of hair color.
The study highlights a critical link: once these stem cells undergo changes that could lead to cancer, they have the potential to migrate to the skin’s upper layers, contributing to the development of melanoma, which can then spread throughout the body. Emi Nishimura, a professor of ageing and regeneration who led the research, explained that both grey hair and melanomas are triggered by the same cellular stress response, but hair follicle cells possess the ability to detect and shut down damaged cells before they become cancerous.
The Body’s Built-In Safeguard: Cell Senescence
Cell senescence isn’t limited to hair follicles; it’s a process that occurs throughout the body, including the skin, gut and lungs. For example, during wound healing, the body intentionally shuts down repair cells once a cut has healed to prevent excessive scarring. Similarly, moles on the skin are essentially clusters of melanocytes that have stopped growing, often because of a cancer-promoting mutation, according to Professor Dot Bennett, a cell biologist at City, University of London.
Still, these senescent cells aren’t always inert. Scientists are now investigating how some damaged cells manage to escape senescence and resume dividing, a process that could contribute to cancer development. “That could eventually support us find ways to push dangerous cells back towards senescence – and away from cancer,” says Professor Bennett.
UV Light: A Bypass to the Protective Mechanism
The research also addressed a crucial question: if hair stem cells respond to DNA damage by shutting down, why doesn’t this happen when damage is caused by overexposure to the sun’s rays, the primary cause of melanoma? The Tokyo team found that exposure to UV light doesn’t trigger the same protective response. Instead, cells continue to divide, increasing the risk of melanoma formation.
What we have is due to the release of a protein called KIT-ligand from surrounding hair follicles when exposed to UV light, which blocks the signal that would normally tell damaged cells to shut down. This finding underscores the importance of sun protection in preventing skin cancer.
Senolytics and the Future of Cancer Prevention
The findings also have implications for the emerging field of senolytics – the development of drugs designed to selectively clear senescent cells from the body. While these cells play a protective role in preventing cancer, their accumulation with age is thought to contribute to age-related illnesses like osteoarthritis and dementia. “Lots of research groups are now working on senolytics,” notes Professor Bennett. “If they are successful, then hair greying and hair loss are among the symptoms that might become treatable.”
A Cautious Outlook and the Mouse Model
While promising, the research findings require further investigation. Professor Desmond Tobin, a dermatological scientist at University College Dublin, cautions that the study was conducted on mice, and hair growth differs significantly between mice and humans. In mice, hair follicles grow in synchronized waves, leading to more frequent division of melanocyte stem cells compared to humans. He adds, “The average age in humans for diagnosis of melanoma is between 60 and 70, long after most people show substantial hair greying.” Melanoma of the scalp is also relatively rare, accounting for only 2 to 5 percent of all skin melanomas and typically remaining confined to the outer layer of the skin.
Professor Tobin believes that unlocking the unique characteristics of hair follicle melanocytes is key to understanding and preventing melanoma. Professor Bennett agrees, emphasizing that the processes of cell senescence differ between mice and humans, which is likely why mice have significantly shorter lifespans.
Further research is needed to determine whether these findings translate to humans and to fully understand the complex interplay between cell senescence, DNA damage, and cancer development. However, this study offers a new perspective on the significance of grey hair, suggesting it may be a visible sign of the body’s inherent ability to fight against cancer.
Disclaimer: This article provides informational content and should not be considered medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
What are your thoughts on this new research? Share your comments below, and please share this article with anyone who might find it informative.
